From: Sublobar resection versus lobectomy in solid-type, clinical stage IA, non-small cell lung cancer
Characteristic | Lobectomy (N = 133) | Sublobar resection (N = 31) | P value |
---|---|---|---|
Mean ± SD or n (%) | Mean ± SD or n (%) | ||
Age | 62.53 ± 9.12 | 69.65 ± 10.94 | <0.001 |
Sex male | 83 (62.41) | 22 (70.97) | 0.413 |
Hypertension | 49 (36.84) | 14 (45.16) | 0.417 |
Diabetes mellitus | 19 (14.29) | 8 (25.81) | 0.175 |
Cardiovascular disease | 8 (6.02) | 9 (29.03) | 0.001 |
Cerebrovascular accident | 3 (2.26) | 3 (9.68) | 0.082 |
Interstitial lung disease | 11 (8.27) | 11 (19.35) | 0.096 |
COPD | 6 (4.51) | 4 (12.90) | 0.096 |
FEV1 | 2.41 ± 0.57 | 2.16 ± 0.66 | 0.087 |
DLCO | 98 ± 19.78 | 75 ± 15.88 | <0.001 |
PET SUVmax | 4.81 ± 3.41 | 5.85 ± 4.45 | 0.386 |